Global Patent Index - EP 4185703 A1

EP 4185703 A1 20230531 - IMPROVED PROCESS FOR PRODUCTION OF CLAVULANIC ACID

Title (en)

IMPROVED PROCESS FOR PRODUCTION OF CLAVULANIC ACID

Title (de)

VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON CLAVULANSÄURE

Title (fr)

PROCÉDÉ DE PRODUCTION D'ACIDE CLAVULANIQUE

Publication

EP 4185703 A1 20230531 (EN)

Application

EP 21749793 A 20210723

Priority

  • EP 20187742 A 20200724
  • EP 2021070660 W 20210723

Abstract (en)

[origin: WO2022018258A1] The present invention relates to a process for the preparation of the β-lactamase inhibitor clavulanic acid by using a microorganism, comprising a step of targeted modifying said microorganism. The present invention is further directed to a process for preparing clavulanic acid by using a microorganism being capable of producing clavulanic acid, but at the same time exhibits reduced or no production of teleocidin A and/or congeners originating from the teleocidin biosynthetic pathway; to a process for preparing clavulanic acid by using a microorganism being capable of producing clavulanic acid, with this process comprising a step of testing said microorganism as to whether it is capable of producing clavulanic acid, but at the same time exhibits reduced or no production of teleocidin A, and/or other congeners originating from the teleocidin biosynthetic pathway; and to a method of testing the suitability of a strain of S. clavuligerus for being used in the production of clavulanic acid, this method comprising a step of assessing whether said strain produces teleocidin A and/or other congeners originating from the teleocidin biosynthetic pathway. The present invention further relates to a method of testing whether a culture broth that is used for culturing S. clavuligerus and producing clavulanic acid has low toxicity, comprising a step of detecting the presence or absence of teleocidin A in said culture broth. Finally, the present invention relates to S. clavuligerus that produces clavulanic acid but reduced or no teleocidin A and/or other congeners originating from the teleocidin biosynthetic pathway.

IPC 8 full level

C12N 15/52 (2006.01); C12N 15/76 (2006.01); C12P 17/18 (2006.01)

CPC (source: EP)

C12N 15/52 (2013.01); C12N 15/76 (2013.01); C12P 17/188 (2013.01)

Citation (search report)

See references of WO 2022018258A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2022018258 A1 20220127; EP 4185703 A1 20230531

DOCDB simple family (application)

EP 2021070660 W 20210723; EP 21749793 A 20210723